IGI Labs (IG) Misses Q1 EPS by 1c, Q2 Revenue Guidance Falls Short
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Tech stocks power S&P 500 to record high as oil prices, producer inflation ease
- Oil pares losses after reports Houthis attacked Saudi Aramco refinery
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Oppenheimer Downgrades IGI Laboratories (IG) to Perform
April 29, 2015 7:51 AM EDTOppenheimer downgraded IGI Laboratories (NYSE: IG) from Outperform to Perform and removed its price target (prior $12.00).
For an analyst ratings summary and ratings history on IGI Laboratories click here. For more ratings news on IGI Laboratories click here.
Shares of IGI Laboratories closed at $7.95 yesterday.
... More